Centurion Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$276K Buy
3,193
+7
+0.2% +$617 0.07% 233
2026
Q2
$249K Sell
3,186
-97
-3% -$7.82K 0.06% 247
2026
Q1
$284K Sell
3,283
-45
-1% -$4.31K 0.06% 241
2025
Q4
$320K Buy
3,328
+54
+2% +$5.24K 0.07% 226
2025
Q3
$312K Sell
3,274
-324
-9% -$29.8K 0.07% 222
2025
Q2
$314K Buy
3,598
+77
+2% +$6.53K 0.09% 172
2025
Q1
$281K Hold
3,521
– – 0.09% 164
2024
Q4
$281K Buy
3,521
+54
+2% +$4.68K 0.09% 164
2024
Q3
$312K Buy
+3,467
New +$292K 0.1% 152
2024
Q1
$266K Buy
3,051
+80
+3% +$6.83K 0.1% 148
2023
Q4
$245K Buy
2,971
+64
+2% +$4.88K 0.1% 143
2023
Q3
$228K Buy
2,907
+152
+6% +$12.7K 0.11% 132
2023
Q2
$243K Sell
2,755
-299
-10% -$25.7K 0.12% 130
2023
Q1
$246K Buy
3,054
+123
+4% +$10K 0.12% 124
2022
Q4
$228K Buy
+2,931
New +$238K 0.13% 132

Other funds holding MDT

Centurion Wealth Management's MDT Position: Q3 2026 in Review

Centurion Wealth Management increased its Medtronic (MDT) stake by 0.22% in Q3 2026, buying an estimated $617 and bringing the position to 3,193 shares worth $276K. The position accounts for 0.07% of the portfolio, ranked #233.

Centurion Wealth Management first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $320K in Q4 2025. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Centurion Wealth Management held 3,193 shares of Medtronic worth $276K as of Q3 2026.
  • Centurion Wealth Management bought 7 Medtronic shares in Q3 2026, an estimated $617.
  • Medtronic made up 0.07% of Centurion Wealth Management's portfolio in Q3 2026, its #233 holding.
  • Centurion Wealth Management first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Centurion Wealth Management's Medtronic position peaked at $320K in Q4 2025.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.